Wineus advised Medgate on a bank financing and co-advised AEVIS VICTORIA on the sale of its 40% stake in Medgate to Otto Group
In 2016, AEVIS acquired a minority stake of 40% in Medgate. Over the past 6 years, AEVIS has significantly invested in the company, helping Medgate to become a key player in telemedicine in Switzerland.
Medgate strives to expand internationally and has thus initiated a financing round in 2021. Since AEVIS’ healthcare activities are focused on the Swiss market and in light of the financing round, AEVIS has sold its participation in Medgate to Otto Group, an ideal successor to support Medgate’s international growth phase as a new majority shareholder. The exit of the participation generated significant cash proceeds for AEVIS in 2022 and a very attractive exit return.
As a preparatory step, a bank financing was structured to buy out a minority shareholder within Medgate at the end of 2021.
Wineus has successfully managed the entire bank financing process for Medgate and accompanied AEVIS through the entire sell-side process as co-advisor.
